Health and Happiness (H&H) International Holdings Limited Stock

Equities

1112

KYG4387E1070

Food Processing

Market Closed - Hong Kong S.E. 04:08:10 2024-05-21 am EDT 5-day change 1st Jan Change
10.48 HKD -2.60% Intraday chart for Health and Happiness (H&H) International Holdings Limited -4.90% -13.39%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 14.98B 2.07B 16.15B Sales 2025 * 16.08B 2.22B 17.34B Capitalization 6.44B 890M 6.95B
Net income 2024 * 867M 120M 935M Net income 2025 * 1.07B 148M 1.15B EV / Sales 2024 * 0.89 x
Net Debt 2024 * 6.87B 950M 7.41B Net Debt 2025 * 6.25B 864M 6.74B EV / Sales 2025 * 0.79 x
P/E ratio 2024 *
7.41 x
P/E ratio 2025 *
6.04 x
Employees 3,174
Yield 2024 *
7.01%
Yield 2025 *
8.68%
Free-Float 32.57%
More Fundamentals * Assessed data
Dynamic Chart
Health and Happiness' Revenue Down 9% in Q1 MT
Health and Happiness (H&H) International Holdings Limited Reports Unaudited Consolidated Revenue Results for the Three Months Ended 31 March 2024 CI
Health and Happiness (H&H) International Holdings Limited Approves Final Dividend for the Year Ended 31 December 2023 CI
Health and Happiness (H&H) International Holdings Limited Proposes Issue and Pricing of USD 120,200,000, 13.5% Senior Notes due 2026 CI
Jefferies Adjusts Health and Happiness International’s Price Target to HK$13 From HK$14, Keeps at Buy MT
H&H’s Profit Down 5% in 2023 MT
Health and Happiness (H&H) International Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on July 10, 2024 CI
Health and Happiness (H&H) International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Health And Happiness (H&H) International to Issue 500 Million Yuan of Bonds MT
Health and Happiness (H&H) International Holdings Limited Announces Pricing of RMB 500,000,000 7.5% Guaranteed Bonds Due 2027 CI
H&H International Warns of Profit Decline MT
Jefferies Adjusts Health and Happiness International’s Price Target to HK$14 From HK$13.10, Keeps at Buy MT
Health and Happiness (H&H) International Holdings Limited Appoints Mrs. Mingshu Zhao Wiggins as Non-Executive Director, Effective from 1 January, 2024 CI
H&H International CEO Steps Down, Sets Up Rotational CEO Structure MT
Health and Happiness (H&H) International Holdings Limited Announces Cessation of Camillo Pane as Chief Executive Officer CI
More news

Latest transcript on Health and Happiness (H&H) International Holdings Limited

1 day-2.79%
1 week-4.91%
Current month+2.35%
1 month+2.95%
3 months-6.61%
6 months-3.15%
Current year-13.55%
More quotes
1 week
10.44
Extreme 10.44
11.24
1 month
9.94
Extreme 9.94
11.24
Current year
9.60
Extreme 9.6
12.58
1 year
8.68
Extreme 8.68
12.70
3 years
6.30
Extreme 6.3
32.80
5 years
6.30
Extreme 6.3
48.35
10 years
6.30
Extreme 6.3
64.50
More quotes
Managers TitleAgeSince
Director of Finance/CFO 50 16-05-02
Chairman 60 10-04-29
Chief Tech/Sci/R&D Officer 57 20-12-31
Members of the board TitleAgeSince
Director/Board Member 68 10-07-11
Chairman 60 10-04-29
Director/Board Member 63 10-05-11
More insiders
Date Price Change Volume
24-05-21 10.48 -2.60% 559 000
24-05-20 10.76 -1.28% 755,500
24-05-17 10.9 -0.55% 1,319,399
24-05-16 10.96 -0.36% 1,408,500
24-05-14 11 -0.18% 1,071,500

Delayed Quote Hong Kong S.E., May 21, 2024 at 03:45 am EDT

More quotes
Health and Happiness (H&H) International Holdings Limited, formerly Biostime International Holdings Ltd., is an investment holding company principally engaged in the manufacture and sale of premium pediatric nutritional. The Company operates through five business segments. The Infant Formulas segment is engaged in the production of infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. The Adult Nutrition and Care Products segment is engaged in the production of vitamins, health supplements, skin care and sports nutrition products for adults. The Probiotic Supplements segment is engaged in the production of probiotic supplements. The Dried Baby Food and Nutrition Supplements segment is engaged in the production of dried baby food products made from natural foods, as well as microencapsulated milk calcium chewable tablets. The Baby Care Products segment is engaged in the production of baby care products.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
9.982 CNY
Average target price
13.5 CNY
Spread / Average Target
+35.21%
Consensus

Quarterly revenue - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW